AI assistant
INSMED Inc — Director's Dealing 2025
Aug 21, 2025
30150_dirs_2025-08-21_07ce065d-69ae-4a55-ab45-8564da1e765a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-08-19
Reporting Person: Adsett Roger (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-19 | Common Stock | S | 20193 | $127.42 | Disposed | 110444 | Direct |
| 2025-08-19 | Common Stock | S | 4807 | $128.27 | Disposed | 105637 | Direct |
Footnotes
F1: This is the weighted average sales price representing 20,193 shares sold at prices ranging from $127.00 to $127.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: This is the weighted average sales price representing 4,807 shares sold at prices ranging from $128.00 to $128.72 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.